Abstract
To maximise the efficiency of template-dependent gene editing, most studies describe programmable and/or RNA-guided endonucleases that make a double-stranded break at, or close to, the target sequence to be modified. The rationale for this design strategy is that most gene repair tracts will be very short. Here, we describe a CRISPR Cas9/gRNA selection-free strategy which uses deep sequencing to characterise repair tracts from a donor plasmid containing seven nucleotide differences across a 216 bp target region in the human CFTR gene. We found that 90% of the template-dependent repair tracts were >100 bp in length with equal numbers of uni-directional and bi-directional repair tracts. The occurrence of long repair tracts suggests that a single gRNA could be used with variants of the same template to create or correct specific mutations within a 200 bp range, the size of ~80% of human exons. The selection-free strategy used here also allowed detection of non-homologous end joining events in many of the homology-directed repair tracts. This indicates a need to modify the donor, possibly by silent changes in the PAM sequence, to prevent creation of a second double-stranded break in an allele that has already been correctly edited by homology-directed repair.
The foundations of contemporary gene editing were laid with two key observations from a plasmid-based study of DNA homologous recombination-dependent DNA repair pathways. The first was the finding that two exogenous DNA molecules containing non-overlapping deletion mutants of the bacterial aminoglycoside 3′-phosphorylase (NeoR) gene could recombine in mammalian cells such that one plasmid served as a template or donor for the precise repair or editing of the other. The second was that the creation of a double-stranded break (DSB) close to the genetic lesion in the NeoR gene in one of the plasmids using a restriction enzyme prior to transfection considerably enhanced the frequency of homologous recombination1.
Whilst proof-of-principle that an exogenous DNA molecule could be used as a template to precisely edit an endogenous genomic sequence was soon established by successful deletion of exon 8 of the hypoxanthine phosphoribosyl transferase gene in mouse embryo-derived stem cells2, experiments to determine the effects of a DSB were more difficult to test due to the lack of endonucleases with sufficient specificity to cut at a unique genomic location. To address this, Jasin and colleagues engineered a human cell line with a NeoR gene containing both a premature stop codon and a unique 18 bp recognition site for the I-SceI meganuclease3. Upon co-transfection of an I-SceI expression vector to create a targeted DSB, and a donor plasmid to act as a template to correct the mutant NeoR gene, they found that gene editing as measured by the production of neomycin-resistant clones, was stimulated by three orders of magnitude compared to cells transfected with the donor alone4. By using donor plasmids with up to eight single nucleotide changes, each creating a novel restriction site without changing the coding sequence of the NeoR gene across a 745 bp region, they were also able to map the extent of repair tract length; analysis of 80 recombinant clones revealed that the majority (75%) of repair tracts were 12 bp or shorter4. Although they also reported a small number of very long tracts in the same study (up to 511 bp), this seminal analysis of repair tracts, along with the original observation from plasmid studies that a DSB close to the target site enhances recombination frequency, have become widely cited in gene editing studies as the rationale for creating DSBs at or close to the target sequence to be modified when using a donor sequence for homology-directed repair (HDR) with programmable and/or RNA-guided endonucleases5,6,7,8,9.
We have previously reported10 the use of template-dependent zinc finger nuclease (ZFN) gene editing to correct the most common cystic fibrosis-causing mutation, F508del, a 3 bp in-frame deletion in the CFTR gene11. Although we observed a high level of ZFN-induced DSBs, the level of editing at the F508del site was at least an order of magnitude lower, which we speculated was most likely a consequence of the large distance (203 bp) between the ZFN target site and the F508del mutation.
Subsequent studies of template-dependent editing of the F508del mutation have utilised powerful selection strategies to successfully correct this mutation in both human gut stem cells12 and human iPS cells13,14,15. However, since these enrichment strategies are not compatible with direct in vivo application of gene editing16, we decided to further characterise template-dependent editing without using a selection approach. Here, we describe a CRISPR Cas9/gRNA strategy to allow the correction of the F508del mutation and characterisation of repair tracts either side of the Cas9-induced DSB by deep sequencing. We observed that 90% of the template-dependent repair tracts were >100 bp with equal numbers of uni-directional and bi-directional repair tracts. Use of a selection-free system also allowed us to detect and characterise template-independent non-homologous end joining (NHEJ) events that occur both independently, and in combination with HDR events.
Results
gRNA design and expression
To analyse the repair tracts of CRISPR/Cas9 gRNA-induced double-stranded breaks (DSBs), we developed a gene targeting assay designed to repair the F508del mutation in human trachael epithelial cells (CFTEs) derived from a cystic fibrosis patient homozygous for this mutation17. We designed two CRISPR guide RNA (gRNA) target sequences that match the GN20GG consensus sequence18,19 in a ~200 bp region of the CFTR gene that spans the intron 10/exon 11 boundary and includes the 3 bp in-frame CTT deletion site which causes the F508del mutation (Fig. 1). To clone and express the gRNAs, we created a one-step cloning vector (see Supplementary Figure S1), based on the U6 promoter-target RNA-guide RNA scaffold plasmid described by Mali and colleagues19, but modified to include two BseRI sites to enable directional Golden Gate cloning20. As the last G residue in the U6 promoter is part of the 3′ overhang generated by the first of the two BseRI sites, DNA fragments made from two oligodeoxynucleotides that encode gRNAs can be cloned without the need to include an additional G at the 5′ end.
Cas9/gRNA cleavage and repair by non-homologous end joining (NHEJ)
To measure the ability of the CRISPR/Cas9 system to create DSB in the CFTR gene, CFTE cells were co-transfected with plasmids encoding Cas9 and either gRNA-in10 or gRNA-ex11. Seventy-two hours post-transfection genomic DNA was analysed by deep sequencing to determine the frequency and size of deletions caused by NHEJ repair of Cas9/gRNA-induced DSBs. As shown in Fig. 1A, the gRNA that targets intron 10 of CFTR resulted in deletions in 1.3% (21/1609) of alleles. In contrast, the gRNA that targets exon 11 of CFTR resulted in a higher deletion rate of 14.3% (192 out of 1346 alleles; Fig. 1B and Supplementary Figure S2). In both cases the deletions are centred at a site approximately 3 bp upstream of the PAM (consistent with the predicted Cas9 cut site), and the majority (70%) of deletions range in size from 4 to 24 bp (Fig. 1 insets). These levels of NHEJ repair and deletion size distribution are similar to that reported in other epithelial cell lines such as 293 cells19. No deletions were observed in deep sequencing analysis of mock transfected cells.
Cas9/gRNAex10 template-dependent editing and repair tract analysis
To evaluate template-dependent editing and characterise the DNA repair tracts, we used a donor plasmid that contains a 216 bp sequence of CFTR centred around the gRNAex11-induced DSB, which includes seven nucleotide differences from the genomic target sequence in CFTE cells in this region (see Fig. 1), and is flanked by ~2 kb homology arms10. The donor plasmid was co-transfected into CFTE cells with Cas9 and gRNAex11 plasmids, and 72 h later, genomic DNA was extracted and analysed by deep sequencing.
As shown in Fig. 2, 1.9% (63 out of 3244) amplicon sequences showed evidence of donor-dependent editing, a similar efficiency to that reported with two different Cas9/gRNA combinations to correct mutations in a GFP reporter gene19. Detailed analysis of the 63 gene-edited tracts by deep sequencing showed two predominant categories of repair. The first comprised 30 long continuous bi-directional tracts, the vast majority of which extend >100 bp either side of the DSB created by Cas9/gRNAex11 as shown by the incorporation of the SNPs and restriction enzyme sites from the donor; in all these bi-directional repair tracts, the 3 bp deletion which causes the F508del mutation in the CFTR protein, located 87 bp downstream of the DSB, was repaired. The second group comprised 30 unidirectional repair tracts, 87% of which were ≥90 bp in length. Nine of these unidirectional tracts occurred in a downstream direction and extend ≥90 bp from the DSB (as evidenced by repair of the F508del mutation which inserts the 3 bp sequence CTT), whereas the other 21 unidirectional repair tracts occurred in an upstream direction; of these, 17 were also long (≥102 bp). A third and minor category (5% of total) was identified comprising three upstream non-continuous repair tracts, two of which had only the G residue in the target sequence replaced by A from the template 102 bp upstream of the DSB, and one with the A residue in the target sequence replaced by G from the template 26 bp upstream of the DSB; none of these tracts had the G to C editing event to create an XhoI site located 8 bp upstream of the DSB.
The use of deep sequencing also allowed us to analyse repair of DSBs by non-homologous end joining. In addition to the 63 amplicon sequences which showed evidence of homology-directed repair (HDR), a further 150 amplicons showed evidence of NHEJ. Closer examination of the 63 template-dependent editing events revealed that just under half also showed evidence of NHEJ events ranging from a 16 bp deletion to a 1 bp insertion (see Fig. 2 and Supplementary Figure S3). If the NHEJ and HDR events that occur in a single amplicon are considered as separate editing events, then the overall ratio of NHEJ:HDR events is 2.8, comparable to the 2.9 ratio reported using the essentially the same CRISPR/Cas9 gRNA vector system to repair human iPS cells with single-stranded oligodeoxynucleotide donors21.
Discussion
Using the human CFTR F508del mutation as a model system, we performed template-dependent editing with S. pyogenes Cas9 and a gRNA that creates a DSB 87 bp upstream of the 3 bp CTT deletion (F508del mutation) and a donor plasmid designed to analyse gene repair tracts of ~100 bp both before and after the DSB. We analysed these tracts without enrichment or selection for editing events by deep sequencing of the target genomic region. The overall level of template-dependent editing was 1.9%, and 90% of these events were long continuous repair tracts in excess of 100 bp from the DSB with no bias towards bi-directional or uni-directional correction.
Our observations that a donor plasmid allows efficient gene editing even when the desired nucleotide change is >100 bp from the Cas9/gRNA cut site, means a wider selection of gRNAs are potentially available to target a particular sequence. It also means a single gRNA could be used with variants of the same template to create or correct specific mutations within a 200 bp range. For example, in the case of exon 11 of CFTR, which is 192 bp long, there are at least 10 other CF-causing mutations in the CFTR2 database22 which could be corrected using the same donor and gRNA combination described herein. Given that 80% of human exons are <200 bp long23, use of a single gRNA/donor combination could be useful to correct such a range of mutations in an individual exon, particularly if a gRNA can be identified in that region with a very low level of off-target binding24. It also means that in the unlikely event that a 200 bp stretch of DNA does not contain an S. pyogenes Cas9 PAM sequence (5′-NGG-3′) on either strand, it should still be possible to edit efficiently by using a PAM just outside of this region. Efficient template-directed gene editing at a distance would also increase the utility of Cas9 with PAMs that have longer and therefore less frequently occurring recognition sequences such as NNGRR(T) in Staphylocccus aureus25 and NNNNGATT in Neisseria meningitidis26. The corollary of these potential advantages of efficient gene editing at distances of ≥100 bp from the DSB is that unwanted changes may inadvertently be introduced into the genome if the homology arms are not identical to the target region, though this is easy to avoid by sequencing both alleles prior to homology arm design27.
A variety of pathways have been proposed to explain DNA repair of a nuclease-induced DSB, but the process of synthesis-dependent strand annealing (SDSA), first described in the study of P element-induced gap repair in Drosophila28, and also known as single end invasion29, appears to offer the best explanation of gene editing when the donor that has homology arms which perfectly match the target sequence on both sides of the DSB8,30. However, SDSA alone does not appear sufficient to explain the formation of uni-directional and bi-directional gene conversion tracts which arise when gene editing is performed with donors comprising homology arms with a low level (~1%) of heterology4,31; in this situation, mismatch repair (MMR) mechanisms are also proposed to play a role in resolving the heteroduplexes formed during recombination32,33. A combination of SDSA and MMR offers an explanation of both the upstream and downstream uni-directional repair tracts we describe here. The first step of the repair process is the resection of both 5′-ends at the DSB (Fig. 3A), creating proximal and distal 3′ single-stranded DNA (ssDNA) exposed tails34. The second step is single end invasion of the donor DNA by one of the exposed 3′ ssDNA tails which creates a displacement loop (D-loop)32,33. The invading DNA strand is then extended using the DNA sequence of the donor plasmid as a template. If the D-loop collapses before the 2nd strand of the chromosome is captured, the newly synthesised DNA strand anneals to the ssDNA tail on the other side of the DSB. The creation of downstream editing tracts commences with strand invasion by the proximal 3′ ssDNA tail such that the newly synthesised DNA would extend by 90 bases before incorporating the CTT triplet (which corrects the CFTR F508del mutation) and then the C SNP of the ClaI site (Fig. 3B). Upon annealing to the proximal ssDNA tail, a heteroduplex DNA tract is created, which if then excised and filled-in by mismatch repair (MMR), would account for the unidirectional repair tracts that occur downstream of the DSB (Figs 2 and S3). Any strands which anneal but cease extension before incorporating the CTT sequence from the donor could potentially repair the DSB, but would not be detected by deep sequencing. The creation of upstream editing tracts starts with strand invasion by the distal 3′ ssDNA tail such that the newly synthesised DNA could be extended to include the C SNP of the XhoI site, then the G SNP, and ultimately the A SNP 102 bp upstream of the DSB (Fig. 3C). Thus, upon annealing to the proximal ssDNA tail, a heteroduplex DNA tract is created, which if then excised and filled-in by mismatch repair (MMR), would account for the unidirectional repair tracts that occur upstream of the DSB (Figs 2 and S3). In situations where the D-loop does not collapse, this would enable a second-strand capture event and formation of a double Holliday junction (dHJ) structure (Fig. 3D shows second capture derived following D-loop formed following single end invasion by distal 3′ ssDNA tail). Non-crossover resolution of this dHJ structure, followed by mismatch repair would account for the bi-directional repair tracts observed (Figs 2 and S3).
These models however do not explain the small number (3/63) of uni-directional template-dependent gene editing events on the 5′ side of the gRNA target site. These three repair tracts show incorporation of either the A residue from the template 102 bp upstream of the DSB or the G residue from the template 26 bp upstream of the DSB, but none of them contain G to C editing event located 8 bp upstream of the DSB. The discontinuous nature of these tracts argues against strand invasion and DNA synthesis from the DSB, however, they could be explained by donor-directed mismatch repair of a single stranded nick in the DNA35. Given that all three of these repair tracts occur upstream of the DSB, this suggests that the nick occurred on the complementary strand, which in CRISPR editing is defined as the DNA strand which has the complementary sequence to the gRNA, and would therefore be created by the HNH domain of Cas936,37,38.
Our finding that the 90% of repair tracts are ≥100 bp differs from the finding in the seminal study of homology repair tracts4 which showed that the 75% of repair tracts are ≤12 bp. Indeed, this study has guided many nuclease-directed template-dependent gene editing strategies to create DSBs close to the target region to be repaired5,6,7,8,9. However, it should be noted that Elliott and colleagues also reported many examples of repair tracts in excess of 100 bp (in one case up to 511 bp), the majority of which were bi-directional. Although the factors which control repair tract length are not fully understood39, a number of differences between our approach and that of Elliott and colleagues4 may contribute to the divergence in the ratio of long:short repair tract length observed between the two studies. In addition to using Cas9/gRNA rather than I-SceI, a key difference is that we used a strategy that monitors repair tracts without the need for selection, whereas Elliott and colleagues4 characterised repair tracts only in cloned cells in which a modified neomycin resistance gene which contained an I-SceI target site with an in-frame stop codon had been successfully corrected. A second difference relates to the level of sequence identity between target and template at the site of the DSB. In our system, the first few bases of the invading 3′ ends created by the Cas9/gRNA DSB and subsequent end-resection have complete sequence identity to the donor template and would allow strand extension without the need for removal of 3′ nonhomologous sequences40,41. In contrast, the first few bases of the invading 3′ ends created at the I-SceI site are non-homologous with the donor template (which contains an NcoI site at the equivalent location4), so these 3′ nonhomologous sequences (9 bases from proximal ssDNA tail, 13 bases from distal ssDNA tail) are most likely resected in order to allow DNA synthesis40,41. If this resection process extends just 8 bases beyond the region of non-homology into the distal tail (the location of the first distal tract marker), this would enable the generation of short homology tracts by SDSA alone (without the need for MMR), which could contribute to the higher ratio of short:long tracts observed in that study.
The overall level of correction of the F508del mutation in just 1.9% of amplicons is still relatively low. However, as transfection efficiency was roughly 30%, then the editing efficiency per transfected cells is expected to be ~3-fold higher; use of a single vector7 to express both gRNA and Cas9 may also improve editing efficiency. The high level of NHEJ events in HDR repair tracts also strongly suggests the need to modify the donor, possibly by silent changes in the PAM sequence, to prevent creation of a second DSB in an allele that has already been correctly edited by HDR. We chose not to modify the PAM sequence in the donor plasmid used here as any change to the NGG sequence would also have disrupted the glycine codon at position 480 of CFTR protein (See Supplementary Figure S2); use of Cas9 from other species with a longer PAM sequence could give more options for modifying the donor without affecting the coding sequence.
In summary, we have shown that in a selection-free system, Cas9/gRNA template-dependent editing gives rise to predominantly long continuous repair tracts with bi-directional and uni-directional events occurring with roughly equal frequency. This allows greater flexibility in selecting gRNAs within a ~200 bp window for template-dependent editing, and suggests that for 80% of exons in the human genome, a single gRNA could be used to create or correct all mutations within an exon.
Materials and Methods
Cell lines and Transfections
The cystic fibrosis tracheal epithelial (CFTE) cell line17 was obtained from Dieter Gruenert (UCSF) and maintained in modified Eagle’s medium (supplemented with 10% foetal calf serum, 1% l-glutamine, and 1% penicillin and streptomycin; Sigma) and incubated at 37 °C and 5% CO2. 300,000 cells were transfected with a total of 4 μg plasmid DNA and 10 μl of Lipofectamine 2000 (Invitrogen).
Plasmids and Golden gate cloning
The donor plasmid was described previously10 and was transfected as intact circular supercoiled molecules. The pGUIDE gRNA expression vector was made by direct DNA synthesis of a 474 bp sequence (see Supplemental Figure S1) into the NotI sites of the pEX-A plasmid (Eurofins Genomics). dsDNA fragments encoding the target sequence of the gRNA (see Supplemental Figure S1) were assembled from two oligos and cloned into pGUIDE by Golden Gate assembly using BseRI/T4 DNA ligase (NEB). Plasmid hCas919 was a gift from George Church (Addgene plasmid #41815).
DNA Repair Tract Detection and Quantification by Deep Sequencing
Genomic DNA was isolated using DNeasy DNA extraction kit (Qiagen). A 2.6-kb PCR product was generated using Platinum pfx (Invitrogen) and primers FP-i9.1 and RP-i10.1. A second PCR was performed using sequencing labelled CFTR-NHEJFor and CFTR-NHEJRev primers to produce a 432 bp product which was subjected to next generation sequencing analysis.
Genomic DNA was isolated and treated with DpnI (NEB) for 90 min at 37 °C to restrict plasmid DNA. A 2.6-kb PCR product was generated using Platinum Taq HF (Invitrogen) and primers 5′-AATTTTGTAAATTTGTTTCATC-3′ and 5′-ACTTGCTTTGCCATTAACAGA-3′. 435-bp amplicons for sequencing by GS FLX++ chemistry (Eurofins Genomics), were generated with the primers 5′-ATCATGTGCCCCTTCTCTGT-3′ and 5′-CGTAGACTAGTGCTTTGATGACGCTTCTGTAT-3′ tagged with a unique 10 nucleotide multiplex-identifier (MID). Sequence alignments were performed using Clustal W42 and MegAlign (Version 11.2.1. DNASTAR. Madison, Wisconsin).
Additional Information
How to cite this article: Hollywood, J. A. et al. Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene. Sci. Rep. 6, 32230; doi: 10.1038/srep32230 (2016).
Supplementary Material
Acknowledgments
The authors wish to thank Dieter Gruenert (Department of Otolaryngology–Head and Neck Surgery, UCSF, San Francisco, CA) for CFTE cell line, George Church (Department of Genetics, Harvard University, Boston, MA) for plasmid hCas9. This work was supported by Cystic Fibrosis Trust (London, UK), the Department of Physiology and College of Medicine and Health, University College Cork, and Cystic Fibrosis Foundation (Bethesda, MD, USA).
Footnotes
Author Contributions J.A.H. and C.M.L. performed and designed experiments, and analysed data; M.F.S. designed experiments; P.T.H. designed experiments, analysed data and wrote the manuscript.
References
- Kucherlapati R. S., Eves E. M., Song K. Y., Morse B. S. & Smithies O. Homologous recombination between plasmids in mammalian cells can be enhanced by treatment of input DNA. Proc Natl Acad Sci USA 81(10), 3153–3157 (1984). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas K. R. & Capecchi M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51(3), 503–512 (1987). [DOI] [PubMed] [Google Scholar]
- Rouet P., Smih F. & Jasin M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol. 14(12), 8096–8106 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elliott B., Richardson C., Winderbaum J., Nickoloff J. A. & Jasin M. Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol. 18(1), 93–101 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Urnov F. D. et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435(7042), 646–651 (2005). [DOI] [PubMed] [Google Scholar]
- Segal D. J. The ‘cutting edge’ of gene therapy … literally Zinc-finger exercises. The Biochemist E-volution 30, 10–13 (2008). [Google Scholar]
- Ran F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 8(11), 2281–2308 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byrne S. M., Ortiz L., Mali P., Aach J. & Church G. M. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 43(3), e21 2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pruett-Miller S. M. & Davis G. D. Donor Plasmid Design for Codon and Single Base Genome Editing Using Zinc Finger Nucleases in Chromosomal Mutagenesis, 2nd edn, Book Series: Methods in Molecular Biology (ed Pruett-Miller S. M.) Vol. 1239, 219–229 (Springer, 2015). [DOI] [PubMed] [Google Scholar]
- Lee C. M., Flynn R., Hollywood J. A., Scallan M. F. & Harrison P. T. Correction of the ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Zinc-Finger Nuclease Homology-Directed Repair. Biores Open Access 1(3), 99–108 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riordan J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922), 1066–1073 (1989). [DOI] [PubMed] [Google Scholar]
- Schwank G. et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13(6), 653–658 (2013). [DOI] [PubMed] [Google Scholar]
- Sargent R. G., Suzuki S. & Gruenert D. C. Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs). Methods Mol Biol. 1114, 279–290 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crane A. M. et al. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells. Stem Cell Reports. 4(4), 569–577 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Firth A. L. et al. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs. Cell Rep. 12(9), 1385–1390 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harrison P. T., Sanz D. J. & Hollywood J. A. Impact of gene editing on the study of cystic fibrosis. Hum. Genet. Epub ahead of print, doi: 10.1007/s00439-016-1693-3 (2016). [DOI] [PubMed] [Google Scholar]
- Kunzelmann K. et al. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol. 8(5), 522–529 (1993). [DOI] [PubMed] [Google Scholar]
- Jinek M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096), 816–821 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mali P. et al. RNA-guided human genome engineering via Cas9. Science 339(6121), 823–826 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Engler C., Kandzia R. & Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS One 3(11), e3647 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang L. et al. Optimization of scarless human stem cell genome editing. Nucleic Acids Res. 41(19), 9049–9061 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Castellani C. and CFTR2 team. CFTR2: How will it help care? Paediatr Respir Rev. 14 Suppl 1, 2–5 (2013). [DOI] [PubMed] [Google Scholar]
- Sakharkar M. K., Chow V. T. & Kangueane P. Distributions of exons and introns in the human genome. In Silico Biol. 4(4), 387–393 (2004). [PubMed] [Google Scholar]
- O’Geen H., Henry I. M., Bhakta M. S., Meckler J. F. & Segal D. J. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res. 43(6), 3389–3404 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ran F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature. 520(7546), 186–191 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hou Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA 110, 15644–15649 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Popplewell L. et al. Gene correction of a duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-in. Hum Gene Ther. 24(7), 692–701 (2013). [DOI] [PubMed] [Google Scholar]
- Nassif N., Penney J., Pal S., Engels W. R. & Gloor G. B. Efficient copying of nonhomologous sequences from ectopic sites via P-element-induced gap repair. Mol Cell Biol. 14(3), 1613–1625 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belmaaza A. & Chartrand P. One-sided invasion events in homologous recombination at double-strand breaks. Mutat Res. 314(3), 199–208 (1994). [DOI] [PubMed] [Google Scholar]
- Moehle E. A. et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104(9), 3055–3060 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nickoloff J. A., Sweetser D. B., Clikeman J. A., Khalsa G. J. & Wheeler S. L. Multiple heterologies increase mitotic double-strand break-induced allelic gene conversion tract lengths in yeast. Genetics 153(2), 665–679 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maloisel L., Fabre F. & Gangloff S. DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension. Mol Cell Biol. 28(4), 1373–1382 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spies M. & Fishel R. Mismatch repair during homologous and homeologous recombination. Cold Spring Harb Perspect Biol. 7(3), a022657, doi: 10.1101/cshperspect.a022657 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Symington L. S. Mechanism and regulation of DNA end resection in eukaryotes. Crit Rev Biochem Mol Biol. 51(3), 195–212 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis L. & Maizels N. Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair. Proc Natl Acad Sci USA 111(10), E924–E932 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishimasu H. et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156(5), 935–949 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sternberg S. H., Redding S., Jinek M., Greene E. C. & Doudna J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.Nature 507(7490), 62–67 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jinek M. et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343(6176), 1247997 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corrigan-Curay J. et al. Genome Editing Technologies: Defining a Path to Clinic Molecular Therapy 23(5), 796–806 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pâques F. & Haber J. E. Two pathways for removal of nonhomologous DNA ends during double-strand break repair in Saccharomyces cerevisiae. Mol Cell Biol. 17(11), 6765–6771 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pâques F. & Haber J. E. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 63(2), 349–404 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Larkin M. A. et al. ClustalW and ClustalX version 2. Bioinformatics 23(21), 2947–2948 (2007). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.